Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

45 recalls, newest first

Class II · Moderate risk

NasalCrom (cromolyn sodium)

CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.

Terminated Microbial contamination Bausch & Lomb, Inc. D-0899-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-208-20 D-0622-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Pharmaceuticals Inc. NDC 0378-3953-09 D-0621-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Pharmaceuticals Inc. NDC 0378-3952-09 D-0620-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Pharmaceuticals Inc. NDC 0378-3951-09 D-0619-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Pharmaceuticals Inc. NDC 0378-3950-77 D-0618-2017
Class II · Moderate risk

Double Hyaluronic 1000

Microbial Contamination of Non-Sterile Products: odor complaint of product due to microbial contamination.

Ongoing Microbial contamination Signature Club A Ltd D-0662-2017
Class II · Moderate risk

Lactulose Solution

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. D-0463-2017
Class II · Moderate risk

Lactulose Solution

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. D-0462-2017
Class II · Moderate risk

Nystatin Oral Suspension

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. NDC 66689-037-99 D-0461-2017
Class II · Moderate risk

Phenytoin Oral Suspension

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. D-0460-2017
Class II · Moderate risk

Metoclopramide Oral Solution

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. D-0459-2017
Class II · Moderate risk

Nystatin Oral Suspension

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. NDC 66689-008-02 D-0457-2017

Recalls by year